← back to search

John F. Thompson

Kaiser Permanente Center for Health Research · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Nonmelanoma Skin Cancer Studies, and Cancer Immunotherapy and Biomarkers.
h-index
136
citations
121,985
works
1,956
NIH funding
primary concept
email

Recent publications

Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status
JAMA Surgery 2024cited by 27position: middledoi
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis
The Lancet Oncology 2024cited by 22position: middledoi
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Journal of Clinical Oncology 2024cited by 11position: middledoi
Treatment of melanoma brain metastases with radiation and immunotherapy or targeted therapy: A systematic review with meta-analysis
Critical Reviews in Oncology/Hematology 2024cited by 10position: lastdoi
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases
Cancer 2024cited by 8position: middledoi
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
JAMA Network Open 2023cited by 17position: middledoi
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Annals of Surgical Oncology 2023cited by 12position: middledoi
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Cancer Discovery 2022cited by 104position: middledoi
Anatomic position determines oncogenic specificity in melanoma
Nature 2022cited by 96position: middledoi
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Journal for ImmunoTherapy of Cancer 2022cited by 57position: middledoi
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
Journal for ImmunoTherapy of Cancer 2022cited by 51position: middledoi
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma
JAMA Surgery 2022cited by 43position: middledoi
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Annals of Surgical Oncology 2022cited by 42position: middledoi
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
Clinical Cancer Research 2022cited by 34position: middledoi
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
EBioMedicine 2022cited by 33position: middledoi
Antagonistic Activity of Lactic Acid Bacteria Against Pathogenic Vibrios and Their Potential Use as Probiotics in Shrimp (Penaeus vannamei) Culture
Frontiers in Marine Science 2022cited by 32position: firstdoi
Radiation therapy for melanoma brain metastases: a systematic review
Radiology and Oncology 2022cited by 22position: firstdoi
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes
Journal of the American Academy of Dermatology 2022cited by 17position: middledoi
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Journal for ImmunoTherapy of Cancer 2022cited by 15position: middledoi
The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness)
Journal of the American Academy of Dermatology 2022cited by 11position: middledoi
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Cancer Cell 2021cited by 162position: middledoi
Tumour gene expression signature in primary melanoma predicts long-term outcomes
Nature Communications 2021cited by 66position: middledoi
Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)
Cancer 2021cited by 61position: middledoi
Association Between Melanoma Detected During Routine Skin Checks and Mortality
JAMA Dermatology 2021cited by 54position: middledoi
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)
JAMA Dermatology 2021cited by 51position: middledoi
Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas
Journal of Clinical Oncology 2021cited by 48position: middledoi
Histological regression in melanoma: impact on sentinel lymph node status and survival
Modern Pathology 2021cited by 32position: middledoi
Predicting sentinel node positivity in patients with melanoma: external validation of a risk‐prediction calculator (the Melanoma Institute Australia nomogram) using a large European population‐based patient cohort*
British Journal of Dermatology 2021cited by 28position: middledoi
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
Pathology 2021cited by 6position: middledoi
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Nature Communications 2020cited by 299position: middledoi

Grants

Collaborative Research: Beyond Procedures: A Research-Based Approach to Teaching Mathematical Methods in Physics
NSF1912087$584,0002019–2025PIRePORTER
Collaborative Research on Learning and Tteaching at the Physics-Mathematics Interface
NSF1405726$237,0262014–2021PIRePORTER
OPUS: The Structure and Dynamics of Selection on Evolving Interactions
NSF1048333$108,7122011–2015PIRePORTER
The geographic mosaic of coevolving plant-insect lineages
NSF0839853$641,3132009–2015PIRePORTER
DISSERTATION RESEARCH: Ecological Structure and Evolutionary Formation of Interspecific Interaction Networks
NSF0514158$11,9702005–2007PIRePORTER
Geographic Mosaics in Diversifying Plant-Insect Interactions
NSF0344147$591,9582004–2009PIRePORTER
Collaborative Research: Research on the Learning and Teaching of Thermal Physics
NSF0406764$107,3812004–2008PIRePORTER
Acquisition of an Ion Trap Mass Spectrometer
NSF0321301$137,3342003–2006PIRePORTER
RUI: Noise Shaping in Complex Nonlinear Optical Systems
NSF0140305$203,0002002–2006PIRePORTER
Geographic Structure of Coevolving Insect/Plant Interactions
NSF0073911$306,0002000–2004PIRePORTER
Shipboard Scientific Support Equipment
NSF9820624$15,2901999–2001PIRePORTER
Shaping of Quantum and Classical Noise in an Optical Fiber Raman Generator
NSF9731230$165,0001998–2002PIRePORTER
Shipboard Scientific Support Equipment
NSF9732010$27,8401998–2000PIRePORTER
Geographic Structure of Evolving Insect/Plant Mutualisms
NSF9707781$346,4081997–2001PIRePORTER
Galois Theory and Finite Projective Planes
NSF9704800$67,5791997–1999PIRePORTER
Shipboard Scientific Support Equipment
NSF9619231$32,0861997–1999PIRePORTER
Ship Operations
NSF9622195$216,0001996–1997PIRePORTER
Noise Evolution in Stokes Raman Scattering in Single-Mode Optical Fiber
NSF9515240$57,1871996–1998PIRePORTER
Shipboard Scientific Support Equipment
NSF9530497$9,7251996–1998PIRePORTER

Frequent collaborators

Richard A. Scolyer · Westmead Institute for Medical Research79 papers (2012–2024)Georgina V. Long · ARC Centre of Excellence in Synthetic Biology34 papers (2012–2024)James S. Wilmott · University of Sydney31 papers (2012–2022)Robyn P.M. Saw · The University of Sydney30 papers (2012–2024)Alexander M. Menzies · Melanoma Institute Australia26 papers (2012–2023)Serigne Lo · Hull York Medical School23 papers (2017–2024)Lauren E. Haydu · Mayo Clinic21 papers (2012–2020)Richard Kefford · Macquarie University18 papers (2012–2020)Jonathan R. Stretch · Melanoma Institute Australia17 papers (2012–2024)Graham J. Mann · Murdoch University16 papers (2012–2021)Kerwin F. Shannon · University of Sydney16 papers (2012–2024)Matteo S. Carlino · Mater Health Services15 papers (2012–2023)Andrew J. Spillane · Australia and New Zealand Banking Group14 papers (2012–2024)Omgo E. Nieweg · The University of Sydney12 papers (2012–2024)Helen Rizos · The University of Sydney11 papers (2012–2020)Hojabr Kakavand · Royal North Shore Hospital11 papers (2013–2017)Angela Hong · The University of Sydney9 papers (2012–2024)Tasnia Ahmed · UNSW Sydney8 papers (2019–2022)Alexander H. R. Varey · University Medical Center Utrecht8 papers (2017–2024)Nicholas K. Hayward · QIMR Berghofer Medical Research Institute8 papers (2013–2019)